UNIVERSITY OF NEW MEXICO
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1889-01-01
- Employees
- 6.7K
- Market Cap
- -
- Website
- https://www.unm.edu/
Bevacizumab (Avastin) Induced Hypertension and Correlation With Tumor Response, a Chart Review
Terminated
- Conditions
- First Posted Date
- 2006-05-08
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 25
- Registration Number
- NCT00322725
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
SGO Society of Gynecologic Oncologists Data Outcomes Project
Terminated
- Conditions
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 100
- Registration Number
- NCT00320996
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Microalbuminuria in Children With and Without Diabetes
Completed
- Conditions
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 203
- Registration Number
- NCT00320086
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Study of Adjuvant Topotecan and Cisplatin With Concurrent Radiation Therapy for Advanced Cervical Cancer
Phase 1
Completed
- Conditions
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 11
- Registration Number
- NCT00320983
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
Terminated
- Conditions
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2024-01-12
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 10
- Registration Number
- NCT00320918
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer
Not Applicable
Withdrawn
- Conditions
- First Posted Date
- 2006-03-01
- Last Posted Date
- 2023-07-05
- Lead Sponsor
- University of New Mexico
- Registration Number
- NCT00298064
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer.
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 22
- Registration Number
- NCT00277004
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung
Completed
- Conditions
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 24
- Registration Number
- NCT00277082
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2010-01-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 33
- Registration Number
- NCT00277069
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
Dysregulated Tyrosine Kinase Signaling in Leukemia
Terminated
- Conditions
- First Posted Date
- 2006-01-13
- Last Posted Date
- 2024-02-07
- Lead Sponsor
- University of New Mexico
- Target Recruit Count
- 30
- Registration Number
- NCT00277056
- Locations
- ๐บ๐ธ
University of New Mexico, Albuquerque, New Mexico, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath